Condition
Chronic Sinusitis, Ethmoidal
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 2 (1)
P 3 (1)
P 4 (1)
Trial Status
Unknown2
Completed1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05095961Phase 2Withdrawn
Pre-operative Steroids in CRSsP
NCT05863468Not ApplicableUnknownPrimary
Quantification of the Airflow Into Sinuses Before and After ArchSinus Implantation
NCT02668302Phase 4CompletedPrimary
The PIO II Study: In-office Post-op Placement of a Steroid-eluting Sinus Implant
NCT03472144Phase 3UnknownPrimary
Gel-Sinuplasty for Chronic Rhinosinusitis With and Without Nasal Polyposis
Showing all 4 trials